Reports

7498 Results (Page 166 of 300)

Pharmaceuticals Markets Research Reports

Pharmaceuticals

Kenya Precision Medicine Market Analysis

Kenya Precision Medicine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Precision Medicine market is growing globally due to the advancements in genomics and molecular biology, increasing adoption of personalized therapies, rising prevalence of chronic diseases, the promise of improved patient outcomes, increasing rate of CNS Disorders such as Alzheimer's disease, epilepsy, multiple sclerosis, increasing partnerships between market players and higher technological advancements of precision medicine. Moderna, Inc., Personalis, Inc., CureVac SE, Celldex Therapeutics, BioNTech SE, Advaxis, Inc., Agenus Inc., Immatics Biotechnologies GmbH, Gritstone Oncology, ImmunityBio, Inc., bioMérieux SA, Bayer AG, Pfizer Inc., GSK plc, F. Hoffmann-La Roche Ltd. are the key market players involved in precision medicine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Chondroitin Market Analysis

Mexico Chondroitin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for chondroitin is driven by factors such as the increasing prevalence of musculoskeletal disorders and osteoarthritis, the growing aging population, rising consumer awareness about the benefits of natural and alternative therapies, and the demand for effective and safe solutions for joint health. Synutra Pure Ltd., TSI Group Ltd. Bioiberica S.A.U., Seikagaku Corporation, etc. are some of the global companies in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Mammography Device Market Analysis

Philippines mammography device market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The demand for mammography equipment is influenced by early cancer detection, cancer fear, and quality of life after a diagnosis. The major key players in this market are Hologic Inc., Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, Siemens Healthcare, Toshiba Medical Systems, GE Healthcare, Metaltronica, Koninklijke Philips N.V., Planmed Oy.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Rituximab Biosimilars Market Analysis

Saudi Arabia Rituximab Biosimilars Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rituximab biosimilars market is growing globally due to the government initiatives, increased healthcare expenditure, increase in biopharmaceutical R&D expenditure, low cost of biosimilars, aging population, increase in healthcare access, patent expiry of reference product, rising prevalence of chronic diseases and growing acceptance and confidence for biosimilars. Teva Pharmaceuticals, Novartis AG, Pfizer, BIOCAD, and Shanghai Henlius Biotech, Inc. are the key global market players in Rituximab Biosimilars Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Diabetic Retinopathy Drugs Market Analysis

South Africa Diabetic Retinopathy Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing prevalence of diabetic retinopathy, technological advancements in drug development, growing awareness and screening programmes, the ageing population, and government initiatives to improve access to screening and treatment for diabetic retinopathy are the drivers of the Diabetic Retinopathy Drugs market. Novartis AG, Regeneron Pharmaceuticals, Allergan plc (part of AbbVie Inc.), Roche Holding AG, Pfizer Inc., Bayer AG, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Bausch Health Companies Inc., Alimera Sciences, are key global companies in diabetic retinopathy drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Multiple Myeloma Drugs Market Analysis

Spain multiple myeloma drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of the illness, new technologies, and improved healthcare systems are a few of the elements boosting the revenue of the worldwide multiple myeloma market. The major key players in this market are Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Genentech Inc. (F. Hoffmann-La Roche Ltd), Novartis AG, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UAE Thin Film Drugs Market Analysis

UAE Thin Film Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Thin Film Drugs market is growing globally due to the pediatric and geriatric applications as they have difficulty in swallowing conventional tablets, technological advancements like development of innovative film-forming materials, improved manufacturing processes and enhanced drug delivery systems, better patient convenience and compliance thereby improving medication adherence, rapid drug absorption and improved bioavailability and increase in research and development activities. Pfizer Inc., Novartis AG, GlaxoSmithKline plc (GSK), Johnson & Johnson Services, Inc., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Aquestive Therapeutics, Inc., Sumitomo Dainippon Pharma Co., Ltd., IntelGenx Corp., ZIM Laboratories Ltd., Indivior PLC, MonoSol Rx (A Subsidiary of MonoSol LLC), LTS Lohmann Therapie-Systeme AG, APR Applied Pharma Research s.a., CURE Pharmaceutical Holding Corp. are the key global market players in thin film drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Gastrointestinal Drugs Market Analysis

US Gastrointestinal Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of gastrointestinal problems, caused by factors such as changing lifestyles, dietary habits, and an ageing population, is one of the main drivers for gastrointestinal medications. Technological advances in drug research and targeted medicines, which provide more effective treatment alternatives, also contribute to market growth. Furthermore, as people become more aware of and diagnose gastrointestinal diseases, the need for medications to treat these conditions grows. Pfizer Inc., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, GlaxoSmithKline plc, Bristol Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., and Allergan plc are among the major global competitors in the gastrointestinal drugs market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Oral Care Market Analysis

Vietnam Oral Care Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030.The global increase in dentists in practise, the prevalence of dental illnesses, and technological developments in oral care products are the key drivers of the oral care market. The global Oral Care market’s major key players are Church and Dwight Co. Inc., Lion Corporation, Dentaid, GlaxoSmithKline, Procter and Gamble, Real Teeth Dental Clinic, Roomchang Dental Hospital, Pachem Dental Clinic, Sunstar Suisse S.A., Johnson and Johnson Consumer Inc., Dr. Fresh LLC, Colgate-Palmolive Company.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Parkinson Disease Market Analysis

Brazil parkinson disease market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key business drivers are anticipated to include the high prevalence of Parkinson's disease (PD) in western countries, the aging global population, which is at a high risk of contracting the disease, and the strong pipeline of drugs that treat the condition. Some of the major key players in this market are Sunovion Pharmaceuticals, Adamas Pharmaceuticals, Neurocrine Biosciences, Supernus Pharmaceuticals, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

China Anti-Venom Market Analysis

China Anti-Venom Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Purified antibodies are used to prevent snake venom from attaching to tissues and causing severe allergic reactions, blood clotting, muscular injury, or nervous system difficulties. The anti-venom market is being driven by the rising global incidence of snakebites, which is fueling demand for effective snakebite treatment options such as anti-venom products. Anti-venom awareness and education efforts have been critical in emphasising the necessity of anti-venom in snakebite management. Manufacturing and delivery techniques advancements have enhanced the safety, efficacy, and accessibility of anti-venom medications. However, market obstacles include restricted access in rural places, high manufacturing costs, a lack of specificity and efficacy in particular formulations, and safety concerns about potential adverse responses and difficulties during therapy.Some global players in the anti-venom market include CSL Limited, BTG plc, Merck & Co., Inc., Pfizer Inc., Sanofi Pasteur SA, Haffkine Bio-Pharmaceutical Corporation Ltd., Rare Disease Therapeutics, Inc., Instituto Bioclon, S.A. de C.V., and Bharat Serums and Vaccines Limited.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Egypt Human Insulin Drugs Market Analysis

Egypt Human Insulin Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. An increasing number of people with diabetes, increased exposure to key diabetes risk factors, rising market demand for human insulin analogues, technological advancements in the field of human insulin delivery devices, and favourable medical reimbursements are all expected to lead to an increase in the global market for human insulin. Some of the key players in this market are Sanofi (France), Novo Nordisk A/S (Denmark), Eli Lilly and Company (U.S.), Biocon Ltd. (India), Julphar (UAE), Ypsomed AG (Switzerland), BD (U.S.), etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

France Pharmaceutical Robots Market Analysis

France Pharmaceutical Robots Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for pharmaceutical robots is rising due to increasing number of medical research activities, increased emphasis on efficiency and productivity of pharmaceuticals. Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB (Switzerland), Denso corporation (Japan), etc. are some of the key players in this market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Indonesia Blood Plasma Market Analysis

Indonesia Blood Plasma Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rising demand for plasma-derived therapies, advancements in plasma fractionation technologies, rising awareness and adoption of plasma-derived therapies, a favourable regulatory environment, increased investment in plasma collection centres, and a growing need for blood plasma in research and development are key drivers in the blood plasma market. CSL Behring, Grifols, Octapharma, Biotest AG, and Kedrion are some of the major global competitors in the blood plasma industry.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Japan Interactive Wound Dressing Market Analysis

Japan interactive wound dressing market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Technology improvements, a growth in the prevalence of chronic wounds, and an increase in surgical procedures are the main factors driving the market for interactive wound dressings. Some of the key players in this market are Johnson & Johnson Medical N.V., Integra LifeSciences Corporation, B. Braun Melsungen AG, Cardinal Health, Medline Industries, Inc., Coloplast Pty Ltd, Medtronic, Beiersdorf AG, Mölnlycke Health Care AB, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Kenya Pressure Sensor Market Analysis

Kenya Pressure Sensor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pressure Sensor market is growing globally due to the rising demand from sectors like consumer electronics, healthcare, automotive, improvements in sensor technology, expanding use of automation, IoT applications, growing demand for pressure sensors in domestic appliances like refrigerators and washing machines. Use of pressure sensors in smartphones, increase in remote connectivity, and advancements in nanoelectromechanical system (NEMS) technology. Fuji Electric Co., Omron Corporation, Broadcom, Panasonic, Infineon Technologies AG, Honeywell International Inc., Siemens, Hitachi automotive system Ltd., Emerson Electric Co., ABB, NXP Semiconductors, STMicroelectronics, Sensata Technologies, Inc., Robert Bosch GmbH, TE Connectivity, Oxensis, Schneider Electric SE, and Baumer are the key global market players in pressure sensor market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Mexico Coenzyme Q10 Market Analysis

Mexico Coenzyme Q10 Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The Coenzyme Q10 market can witness growth due to factors such as increased consumer awareness, rising demand for dietary supplements and functional foods, growing interest in anti-aging and cardiovascular health applications in healthcare, the aging population, rising health consciousness, and product innovation. Prominent global players in the Coenzyme Q10 (CoQ10) market include Kaneka Corporation, DSM Nutritional Products, Hwail Pharmaceutical Co., Ltd., Tishcon Corporation, and Healthy Origins.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Philippines Medical Cannabis Drugs Market Analysis

Philippines medical cannabis drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Globally, there are more people with chronic illnesses, which will probably result in an increase in patients, and people are becoming more interested in living healthy lives. Additionally, it's projected that a rise in product approvals and increased R&D for cannabis-related medical devices will fuel market growth. The major key players in this market are Tilray, Bedrocan International, Canopy Growth Corporation, Aurora Cannabis Inc., Vivo Cannabis Inc., Maricann Inc., Medical Marijuana Inc., Organigram Holdings Inc., The Scotts Company LLC, Curaleaf Holdings, Inc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Saudi Arabia Rotavirus Vaccine Market Analysis

Saudi Arabia Rotavirus Vaccine Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Rotavirus Vaccine market is growing globally due to the rising burden of rotavirus infection, government immunization programs, increasing awareness and education about rotavirus infection, improved vaccine coverage, research and development activities to improve the safety and efficacy of rotavirus vaccine, international support from world health organization. Merck & Co., Inc., Bharat Biotech, GlaxoSmithKline plc., Sanofi, Lanzhou Institute of Biologicals Products Co., Ltd, BIOVIRx Inc, Serum Institute of India Pvt. Ltd., Biological E, Bio Farma, Novartis AG, Berghofer Medical Research Institute, Pfizer, Inc., CSL Limited, Emergent BioSolutions, Inc., Johnson & Johnson Services, Inc., AstraZeneca, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation., DAIICHI SANKYO COMPANY, LIMITED are the key global market players in rotavirus vaccine market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

South Africa Diabetic Retinopathy Therapeutic Market Analysis

South Africa Diabetic Retinopathy Therapeutic Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Increasing prevalence of diabetes, growing awareness and early diagnosis, advancements in technology and treatment options, government initiatives and healthcare expenditure, and the aging population are the drivers of the diabetic retinopathy therapeutic market. Prominent global players in the market include Novartis AG, Roche Holdings AG, Regeneron Pharmaceuticals, Bayer AG, Allergan plc (AbbVie Inc.), Alimera Sciences, Bausch Health Companies Inc., Topcon Corporation, Carl Zeiss Meditec AG and NIDEK Co., Ltd.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Spain Nanomedicine Market Analysis

Spain nanomedicine market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Shortly, significant advancements and the recent commercialization of goods like mRNA- and liposome-based vaccines are anticipated to fuel the rise of nanomedicines. The major key players in this market are Abbott Laboratories, CombiMatrix Corporation, Celgene Corporation, etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

UAE TNF Inhibitors Market Analysis

UAE TNF Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. TNF Inhibitors market is growing globally due to the rising prevalence of autoimmune diseases like rheumatoid arthritis, psoriasis, psoriatic arthritis, inflammatory bowel disease for which TNF Inhibitors are used. Increase in number of research and development activities in tumor necrosis factor (TNF) inhibitor drugs, increasing acceptance of biologic therapies, expanding indications of TNF Inhibitors like dermatologic disorders, ophthalmic diseases, and neurological disorders and growth in ageing population. AbbVie Inc., Amgen Inc., Johnson & Johnson (Janssen Biotech, Inc.), Pfizer Inc., Novartis International AG, UCB S.A., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Samsung Bioepis Co., Ltd., Sandoz International GmbH are the key global market players in TNF Inhibitors Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

US Generic and Biosimilar Pharmaceutical Market Analysis

US Generic and Biosimilar Pharmaceutical Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The generic and biosimilar pharmaceutical market is driven by cost-effectiveness, patent expirations, rising healthcare demand, and government cost-cutting initiatives. Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH (Novartis), Pfizer Inc., Amgen Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, Celltrion Inc., and Stada Arzneimittel AG are global companies in the Generic and Biosimilar Pharmaceutical Market.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Vietnam Oral Contraceptives Market Analysis

Vietnam oral contraceptives market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growth drivers for the market are raising awareness of the advantages of oral contraceptives, increasing the proportion of women working, increasing the number of sexually transmitted diseases (STIs), increasing the usage of reversible long-acting contraception (LARCs), Increasing the number of internet pharmacies. Some of the major key players in this market are Allergan plc, Bayer AG, Johnson & Johnson Services, Inc., Mankind Pharma Ltd., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

Pharmaceuticals

Brazil Pediatric Healthcare Market Analysis

Brazil pediatric healthcare market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growth in the number of kids who need special care, greater knowledge of home healthcare, technological advancements, and rising disposable money are the market's main drivers. The life expectancy of newborns has increased as a result of improvements in medical intervention techniques. Some of the major key players in this market are Abbott, AstraZeneca, GlaxoSmithKline, Merck & Co., etc.

PUBLISHED: Feb, 2024 | FORMAT: PPT | LAST UPDATED: Feb, 2024 | PRICE: $3999

subscribe to our newsletter
up